Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shilpa Ramaswamy

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Neurobiology of Disease|January 7, 2012
Gene therapy for Huntington's diseaseShilpa Ramaswamy, Jeffrey H Kordower
Parkinsonism & Related Disorders|January 20, 2010
Are growth factors the answer?Shilpa Ramaswamy, Jeffrey H Kordower
Progress in Brain Research|August 8, 2009
Trophic factors therapy in Parkinson's diseaseShilpa Ramaswamy, Katherine E Soderstrom, Jeffrey H Kordower
ILAR Journal|August 23, 2007
Animal models of Huntington's diseaseShilpa Ramaswamy, Jodi L McBride, Jeffrey H Kordower
Cell Transplantation|May 17, 2007
Huntington's disease: pathological mechanisms and therapeutic strategiesShilpa Ramaswamy, Kathleen M Shannon, Jeffrey H Kordower
Brain Research|July 30, 2005
Cellular proliferation and migration following a controlled cortical impact in the mouseShilpa Ramaswamy, Gwen E Goings, Katherine E Soderstrom, et al.
Cell Reports|August 27, 2013
Regulation of cyclic AMP response element binding and hippocampal plasticity-related genes by peroxisome proliferator-activated receptor αAvik Roy, Malabendu Jana, Grant T Corbett, et al.
Neurobiology of Disease|March 6, 2007
Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's diseaseShilpa Ramaswamy, Jodi L McBride, Christopher D Herzog, et al.
Neurobiology of Disease|January 20, 2009
Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's diseaseShilpa Ramaswamy, Jodi L McBride, Ina Han, et al.
BMC Endocrine Disorders|June 27, 2021
Similar immunogenicity profiles between the proposed biosimilar MYL-1501D and reference insulin glargine in patients with diabetes mellitus: the phase 3 INSTRIDE 1 and INSTRIDE 2 studiesBin Sun, Nilanjan Sengupta, Anita Rao, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Neurobiology of Disease|January 7, 2012
Gene therapy for Huntington's diseaseShilpa Ramaswamy, Jeffrey H Kordower
Parkinsonism & Related Disorders|January 20, 2010
Are growth factors the answer?Shilpa Ramaswamy, Jeffrey H Kordower
Progress in Brain Research|August 8, 2009
Trophic factors therapy in Parkinson's diseaseShilpa Ramaswamy, Katherine E Soderstrom, Jeffrey H Kordower
ILAR Journal|August 23, 2007
Animal models of Huntington's diseaseShilpa Ramaswamy, Jodi L McBride, Jeffrey H Kordower
Cell Transplantation|May 17, 2007
Huntington's disease: pathological mechanisms and therapeutic strategiesShilpa Ramaswamy, Kathleen M Shannon, Jeffrey H Kordower
Brain Research|July 30, 2005
Cellular proliferation and migration following a controlled cortical impact in the mouseShilpa Ramaswamy, Gwen E Goings, Katherine E Soderstrom, et al.
Cell Reports|August 27, 2013
Regulation of cyclic AMP response element binding and hippocampal plasticity-related genes by peroxisome proliferator-activated receptor αAvik Roy, Malabendu Jana, Grant T Corbett, et al.
Neurobiology of Disease|March 6, 2007
Neurturin gene therapy improves motor function and prevents death of striatal neurons in a 3-nitropropionic acid rat model of Huntington's diseaseShilpa Ramaswamy, Jodi L McBride, Christopher D Herzog, et al.
Neurobiology of Disease|January 20, 2009
Intrastriatal CERE-120 (AAV-Neurturin) protects striatal and cortical neurons and delays motor deficits in a transgenic mouse model of Huntington's diseaseShilpa Ramaswamy, Jodi L McBride, Ina Han, et al.
BMC Endocrine Disorders|June 27, 2021
Similar immunogenicity profiles between the proposed biosimilar MYL-1501D and reference insulin glargine in patients with diabetes mellitus: the phase 3 INSTRIDE 1 and INSTRIDE 2 studiesBin Sun, Nilanjan Sengupta, Anita Rao, et al.
Pageof 2